InvestorsHub Logo
Followers 800
Posts 50875
Boards Moderated 2
Alias Born 12/12/2004

Re: crudeoil24 post# 55

Friday, 08/27/2021 9:07:31 AM

Friday, August 27, 2021 9:07:31 AM

Post# of 87
The agreement with Jiangsu Hengrui is in the Greater China area for BeyondSpring's investigational drug candidate plinabulin. Plinabulin in combination with G-CSF is currently under review by the U.S. Food and Drug Administration and the China National Medical Products Administration to prevent chemotherapy-induced neutropenia. The territory for the agreement includes mainland China, Hong Kong, Macau and Taiwan.

New York Yankees and Duke Basketball

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BYSI News